Chapter 10-35 - PUBLICLY TRADED CORPORATIONS

Section 10-35-01 - Citation
Section 10-35-02 - Definitions
Section 10-35-03 - Application and effect of chapter
Section 10-35-04 - Application of chapter 10-19.1
Section 10-35-05 - Amendment of the bylaws
Section 10-35-06 - Board of directors
Section 10-35-07 - Nomination of directors
Section 10-35-08 - Access to corporation's proxy statement
Section 10-35-09 - Election of directors
Section 10-35-10 - Reimbursement of proxy expenses
Section 10-35-11 - Supermajority provisions prohibited
Section 10-35-12 - Regular meeting of shareholders
Section 10-35-13 - Call of special meeting of shareholders
Section 10-35-14 - Shareholder proposals of business at a regular meeting
Section 10-35-15 - Shareholder proposals of amendment of the articles
Section 10-35-16 - Requirements for convening shareholder meetings
Section 10-35-17 - Approval of certain issuances of shares
Section 10-35-18 - Pre-emptive rights
Section 10-35-19 - Conduct and business of shareholder meetings
Section 10-35-20 - Action by shareholders without a meeting
Section 10-35-21 - Financial statements
Section 10-35-22 - Duration of poison pills limited
Section 10-35-23 - Protection of power of current directors over poison pill
Section 10-35-24 - Minimum share ownership triggering level for poison pills
Section 10-35-25 - Optional restrictions or prohibitions on poison pills
Section 10-35-26 - Adoption of antitakeover provisions
Section 10-35-27 - Liberal construction
Section 10-35-28 - Annual report - Franchise fee
Section 10-35-29 - Filing of annual report and payment of publicly traded corporation franchise fee
Section 10-35-30 - Collection of publicly traded corporation franchise fee - Preferred debt
Section 10-35-31 - Penalties - Administrative dissolution
Section 10-35-32 - Secretary of state - Powers - Enforcement - Penalty - Appeal
Section 10-35-33 - Funds received